This is an open procedure for awarding health surveillance services for MM S.p.A. The services include laboratory tests, specialized laboratory examinations, second-level medical visits, and vaccinations. The contract also requires periodic reporting and the registration of vaccinations on a managem
Tender closed on 23 Jan 2026. Awaiting award.
This contract opportunity involves the supply of electrical equipment and spare parts for medium and low voltage systems installed at the Nosedo and San Rocco wastewater treatment plants in Milan. The contract also includes specialized maintenance services for these systems. Suppliers are invited to
This contract opportunity involves the management and development of ICT (Information and Communication Technology) infrastructures for MM S.p.A. The services sought include overseeing existing data transmission networks and enhancing their capabilities. Suppliers are invited to submit proposals for
The City of Milan is seeking suppliers to provide both regular and emergency maintenance services for public green spaces. This contract is divided into three non-cumulative lots, allowing suppliers to bid on one or more lots. The total value of the contract is approximately €9,914,400. Interested s
This contract opportunity is for the maintenance services of the MMETROLINK network. The buyer, MM S.p.A., is seeking qualified suppliers to provide comprehensive maintenance for data transmission equipment. The goal is to ensure the reliability and efficiency of the network. Interested suppliers sh
NHS teaching hospital trust seeks qualified providers for urgent treatment centre services across multiple sites, with contract value up to £2.5m annually and start date of April 2027.
Join a virtual market engagement event on 14 September 2026 to discuss delivering a £10 million work and health early-intervention service across Nottinghamshire, Lincolnshire and Derbyshire.
Tender opportunity to provide General Dental Services across Gwent under the Aneurin Bevan University Health Board.
NHS England is seeking a supplier framework agreement for Ruxolitinib, a pharmaceutical product, for the period April 2028 to March 2029 with possible extension.
